Da Yang

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Venues

Nature communications

Science advances

Molecular carcinogenesis

Research square

University of Pittsburgh

Harbin Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pittsburgh Sep 01 2014

United States

Assistant Profressor :: Pharmaceutical Sciences

University of Texas MD Anderson Cancer Center Sep 01 2009 - Aug 31 2014

United States

Odyssey Fellow :: Pathology

Education History

Harbin Medical University Sep 01 2005 - Jun 30 2009

China

PHD :: Pharmacology

Publications

Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Yue Wang, Dhamotharan Pattarayan, Haozhe Huang, Yueshan Zhao, Sihan Li, Yifei Wang, Min Zhang, Song Li, Da Yang
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer. Nature communications 15 (1) (2024)
Yue Wang, Dhamotharan Pattarayan, Haozhe Huang, Yueshan Zhao, Sihan Li, Yifei Wang, Min Zhang, Song Li, Da Yang
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Yue Wang, Dhamotharan Pattarayan, Haozhe Huang, Yueshan Zhao, Sihan Li, Yifei Wang, Min Zhang, Song Li, Da Yang
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Yue Wang, Dhamotharan Pattarayan, Haozhe Huang, Yueshan Zhao, Sihan Li, Yifei Wang, Min Zhang, Song Li, Da Yang
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Yue Wang, Dhamotharan Pattarayan, Haozhe Huang, Yueshan Zhao, Sihan Li, Yifei Wang, Min Zhang, Song Li, Da Yang
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer. Nature communications 15 (1) (2024)
Da Yang, Yue Wang, Dhamotharan Pattarayan, Haozhe Huang, Yueshan Zhao, Sihan Li, Yifei Wang, Min Zhang, Song Li
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer. Research square (2023)
Avishek Bhuniya, Dhamotharan Pattarayan, Da Yang
Lentiviral vector transduction provides nonspecific immunogenicity for syngeneic tumor models. Molecular carcinogenesis 61 (12) (2022)
Yifei Wang, Yueshan Zhao, Weiwei Guo, Ghanshyam Singh Yadav, Chetana Bhaskarla, Zehua Wang, Xiaofei Wang, Sihan Li, Yue Wang, Yuang Chen, Dhamotharan Pattarayan, Wen Xie, Song Li, Binfeng Lu, Udai S Kammula, Min Zhang, Da Yang
Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response. Science advances 8 (49) (2022)
Weiwei Guo, Yue Wang, Min Yang, Zehua Wang, Yifei Wang, Smriti Chaurasia, Zhiyuan Wu, Min Zhang, Ghanshyam Singh Yadav, Sanjay Rathod, Fernando Concha-Benavente, Christian Fernandez, Song Li, Wen Xie, Matthew J Ferris, Udai S Kammula, Binfeng Lu, Da Yang
LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance. Science advances 7 (7) (2021)
Yue Xi, Yanping Li, Peng-Fei Xu, Sihan Li, Zhengsheng Liu, Hung-Chun Tung, Xinran Cai, Jingyuan Wang, Haozhe Huang, Menglin Wang, Meishu Xu, Songrong Ren, Song Li, Min Zhang, Yong J Lee, Leaf Huang, Da Yang, Jinhan He, Zhiying Huang, Wen Xie
The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1. Science advances 7 (36) (2021)
Zhuoya Wan, Runzi Sun, Yang-Wuyue Liu, Sihan Li, Jingjing Sun, Jiang Li, Junjie Zhu, Pearl Moharil, Bei Zhang, Pengfei Ren, Guolian Ren, Min Zhang, Xiaochao Ma, Shuangshuang Dai, Da Yang, Binfeng Lu, Song Li
Targeting metabotropic glutamate receptor 4 for cancer immunotherapy. Science advances 7 (50) (2021)
Ben Liu, Meng Zhou, Xiangchun Li, Xining Zhang, Qinghua Wang, Luyang Liu, Meng Yang, Da Yang, Yan Guo, Qiang Zhang, Hong Zheng, Qiong Wang, Lian Li, Xinlei Chu, Wei Wang, Haixin Li, Fengju Song, Yuan Pan, Wei Zhang, Ke-Xin Chen
Interrogation of gender disparity uncovers androgen receptor as the transcriptional activator for oncogenic miR-125b in gastric cancer. Cell death & disease 12 (5) (2021)
Zihui Fang, Yue Wang, Zehua Wang, Meishu Xu, Songrong Ren, Da Yang, Mei Hong, Wen Xie
ERINA Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway. Cancer research 80 (20) (2020)
Yifei Wang, Min Zhang, Zehua Wang, Weiwei Guo, Da Yang
MYC-binding lncRNA EPIC1 promotes AKT-mTORC1 signaling and rapamycin resistance in breast and ovarian cancer. Molecular carcinogenesis 59 (10) (2020)
Stephen Kalscheuer, Vidhi Khanna, Hyunjoon Kim, Sihan Li, Deepali Sachdev, Arthur DeCarlo, Da Yang, Jayanth Panyam
Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer. Scientific reports 9 (1) (2019)

Da Yang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Da Yang